L-asparaginase biosimilar (Laboratorios Bioprofarma)

L-天冬酰胺酶生物类似药 (Laboratorios Bioprofarma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameL-asparaginase biosimilar (Laboratorios Bioprofarma)
Drug Alias NameL-天冬酰胺酶生物仿制药 (Laboratorios Bioprofarma)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsLymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsLymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date2013/08/01
Country/TerritoryFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Bioprofarma
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Bioprofarma
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeL01XX02
Related LinksN/A